AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $276,000 | +37.3% | 9,338 | +185.7% | 0.18% | +108.0% |
| Q3 2018 | $201,000 | -9.9% | 3,269 | -20.5% | 0.09% | +63.0% |
| Q1 2018 | $223,000 | -37.2% | 4,112 | -43.7% | 0.05% | -46.5% |
| Q3 2017 | $355,000 | -43.7% | 7,300 | -39.2% | 0.10% | -53.7% |
| Q2 2017 | $631,000 | +45.7% | 12,000 | +25.5% | 0.22% | +23.2% |
| Q1 2017 | $433,000 | +78.9% | 9,558 | +49.3% | 0.18% | +39.4% |
| Q4 2016 | $242,000 | – | 6,400 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |